###begin article-title 0
A test of the model that RNA polymerase III transcription is regulated by selective induction of the 110 kDa subunit of TFIIIC
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License () which permits unrestricted non-commerical use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 811 818 811 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 134 139 <span type="species:ncbi:9606">human</span>
TFIIIC is a RNA polymerase (pol) III-specific DNA-binding factor that is required for transcription of tRNA and 5S rRNA genes. Active human TFIIIC consists of five subunits. However, an inactive form has also been isolated that lacks one of the five subunits, called TFIIIC110. A model was proposed in which pol III transcription might be regulated by the specific induction of TFIIIC110, allowing formation of active TFIIIC from the inactive form. We have tested this model by transient transfection of HeLa and HEK293 cells with a vector expressing TFIIIC110. We have also made stably transfected HeLa cell lines that carry a doxycycline-inducible version of the cDNA for TFIIIC110. We show that the induced TFIIIC110 enters the nucleus, binds other TFIIIC subunits and is recruited to tRNA and 5S rRNA genes in vivo. However, little or no effect is seen on the expression of pol III transcripts. The data argue against the model that pol III transcription can be effectively modulated through the specific induction of TFIIIC110.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 192 193 192 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 194 195 194 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 349 350 349 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 351 352 351 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 436 460 436 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Saccharomyces cerevisiae</italic>
###xml 552 553 552 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 554 555 554 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 430 435 <span type="species:ncbi:4932">yeast</span>
###xml 436 460 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
TFIIIC is a large DNA-binding factor that directly recognizes the promoter sequences found within most pol III-transcribed genes, including tRNA and 7SL RNA genes and the adenoviral VA genes (1-3). It is also required for transcription of 5S rRNA genes, although in this case its recruitment is dependent on an additional polypeptide called TFIIIA (1-3). Indeed, it is probable that TFIIIC is used by all pol III templates in the yeast Saccharomyces cerevisiae, although it is not necessary for pol III transcription of mammalian U6 and 7SK RNA genes (1-3).
###end p 4
###begin p 5
###xml 78 79 78 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 80 81 80 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 318 319 297 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 434 435 413 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 548 549 527 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">6</xref>
###xml 550 551 529 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 552 554 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">11</xref>
###xml 637 638 616 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 787 788 766 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 972 973 951 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 974 975 953 954 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 976 978 955 957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 1141 1142 1120 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 1143 1145 1122 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 1313 1321 1292 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 1477 1479 1456 1458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 1625 1626 1604 1605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 1627 1628 1606 1607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 1629 1631 1608 1610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human TFIIIC has been purified from HeLa cells as a complex of five subunits (4-6). These are commonly referred to as TFIIIC220, TFIIIC110, TFIIIC102, TFIIIC90 and TFIIIC63, according to their approximate molecular masses. An alternative nomenclature of TFIIICalpha, beta, gamma, delta and epsilon has also been used (7). The complex is stable, as the subunits remain associated following immunoprecipitation and washing in 1 M NaCl (8). Cloning of cDNAs for all five subunits has allowed confirmation that each is a bona fide component of TFIIIC (6,8-11). However, the complex has also been purified with the TFIIIC110 subunit missing (5). Furthermore, calculations based on metabolic labeling suggested that TFIIIC from cycling HeLa cells contains half as much TFIIIC110 as TFIIIC220 (7). TFIIIC complexes with or without the 110 kDa subunit were dubbed TFIIIC2a and TFIIIC2b, respectively, and shown to be resolved on non-denaturing gels or by gradient chromatography (5,9,12). Although the two forms produced identical footprints and had similar DNA-binding affinities, the complex without TFIIIC110 was unable to support transcription (5,12). These observations lead to a model in which TFIIIC activity could be regulated by reversible interaction of the TFIIIC110 subunit with the remainder of the complex (Figure 1). The interaction might be controlled by phosphorylation, as TFIIIC2b could be generated by phosphatase treatment of fractions containing active TFIIIC2a (12). The model was proposed to explain pol III transcriptional induction observed when HeLa cells are stimulated with serum or with adenoviral E1A (5,9,12).
###end p 5
###begin p 6
###xml 122 123 122 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 124 125 124 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 126 128 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 143 149 143 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 528 529 528 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 729 731 729 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 732 734 732 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 944 946 944 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 947 949 947 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 635 640 <span type="species:ncbi:9606">human</span>
###xml 683 687 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 709 715 <span type="species:ncbi:10090">murine</span>
###xml 820 824 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
The E1A oncoprotein of adenovirus can stimulate pol III transcription, probably through several complementary mechanisms (5,9,12-20). Hoeffler et al. (12) reported that the ratio of active TFIIIC2a to inactive TFIIIC2b, as measured by electrophoretic mobility shift assay (EMSA), is higher in HeLa cells infected with wild-type adenovirus than in cells infected with the E1A deletion mutant dl312. In support of this, western blotting revealed lower levels of TFIIIC110 following dl312 infection, compared with wild-type virus (9). EMSA analysis also suggested that the ratio of TFIIIC2a to TFIIIC2b is elevated in the E1A-transformed human embryonic kidney cell line 293 and in two SV40-transformed lines of murine fibroblasts (12,21). Subsequent studies found that all five subunits of TFIIIC are overexpressed in the SV40-transformed fibroblasts compared to untransformed parental cells, although the effect appears strongest for TFIIIC110 (22,23).
###end p 6
###begin p 7
###xml 116 122 116 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 461 462 461 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
The rate of synthesis of pol III products is influenced strongly in mammalian cells by serum availability. Hoeffler et al. (12) reported that the relative proportion of TFIIIC2a to TFIIIC2b was reduced in HeLa cells grown in low serum, an effect which correlated with the reduced transcriptional activity. Consistent with this, western blotting revealed a decrease in expression of TFIIIC110 under low serum conditions, whereas TFIIIC220 levels were unchanged (9). A selective change in TFIIIC110 expression was therefore proposed as a mechanism allowing the pol III machinery to adapt to serum availability.
###end p 7
###begin p 8
###xml 13 21 13 21 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
The model in Figure 1 was based on correlative data-relatively high ratios of TFIIIC2a to TFIIIC2b and of TFIIIC110 to TFIIIC220 seen in transcriptionally active extracts from cells grown in the presence of E1A or high serum. However, these observations did not distinguish between cause and effect. The data are compatible with the possibility that selective loss of TFIIIC110 might occur as a consequence of down-regulated transcription, rather than having a causative role. For example, surplus TFIIIC might be degraded when active transcription is not occurring and TFIIIC110 might simply be less stable than the other subunits and therefore removed first, allowing accumulation of TFIIIC2b. Therefore, we tested the model directly by determining whether a specific induction of TFIIIC110 is sufficient to stimulate pol III transcription.
###end p 8
###begin title 9
MATERIALS AND METHODS
###end title 9
###begin title 10
Cell culture
###end title 10
###begin p 11
HeLa and HEK293 cells were cultured in DMEM supplemented with 10% FBS, 100 U/ml penicillin and 100 mug/ml streptomycin. HeLa TET-ON cells were cultured in 10% FBS (tetracycline free), 100 U/ml penicillin, 100 mug/ml streptomycin and 100 mug/ml G418. Stably transfected HeLa TET-ON cells were also supplemented with 100 mug/ml hygromycin. Expression of HA-TFIIIC110 and HA-Brf1 was induced by the addition of 1 mug/ml doxycycline for 48 h.
###end p 11
###begin title 12
HeLa cell proliferation assay
###end title 12
###begin p 13
###xml 29 30 29 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 60 61 60 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
Cells were plated on to 75 cm2 flasks at a density of 5 x 105 cells per plate, in media containing 0.5% or 10% FBS. Viable cells were counted every 24 h using trypan blue staining and a haemocytometer.
###end p 13
###begin title 14
Transient and stable transfection
###end title 14
###begin p 15
Transient transfection of HeLa and HEK293 cells were carried out using Lipofectamine. Stable transfection of HeLa TET-ON cells were also achieved using Lipofectamine. Stable transformants were selected using 200 mug/ml hygromycin.
###end p 15
###begin title 16
Plasmids
###end title 16
###begin p 17
###xml 39 41 39 41 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 162 165 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 332 337 <span type="species:ncbi:9606">Human</span>
pVA1 contains the adenovirus VA1 gene (24). pEGFP (Clontech) contains a cDNA encoding a derivative of green fluorescent protein expressed from a cytomegalovirus (CMV) promoter. pTRE2hygHA-Brf1 was produced by PCR amplification and sub-cloning into the pTRE2hyg vector (Clontech) the HA-Brf1 coding sequence from pcDNA3HA-Brf1 (25). Human TFIIIC110 was PCR amplified from the pRSET-TFIIIC110 vector (a kind gift from Robert Roeder) and subcloned into pcDNA3HA, generating pcDNA3HA-TFIIIC110. HA-TFIIIC110 was subsequently subcloned into pTRE2hyg, again by PCR, to generate pTRE2hygHA-TFIIIC110.
###end p 17
###begin title 18
Western blotting and antibodies
###end title 18
###begin p 19
###xml 662 664 649 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">26</xref>
Cells were washed twice with ice-cold phosphate-buffered saline (PBS) and scraped into lysis buffer [20 mM HEPES (pH 7.8), 150 mM NaCl, 25% glycerol, 50 mM NaF, 0.2 mM EDTA, 0.5% Triton X-100, 0.5% NP-40, 10 mM beta-glycerophosphate, 1 mM sodium orthovanadate, 1 mM phenylmethlysulfonyl fluoride (PMSF), 1 mM DTT, 0.5 mug/ml leupeptin, 1.0 mug/ml trypsin inhibitor, 0.5 mug/ml aprotinin and 40 mug/ml bestatin]. Lysates were incubated on ice for 10 min and passed through a 26-gauge needle three times, before centrifugation at 16 000 G for 10 min at 4degreesC. The supernatant was collected for immunoblot analysis, which was performed as described previously (26).
###end p 19
###begin p 20
###xml 312 313 312 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 320 322 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 385 392 <span type="species:ncbi:9986">rabbits</span>
###xml 433 438 <span type="species:ncbi:9606">human</span>
Antibodies were F-7 against HA, SI-1 against TFIIB, C11 against actin and R-124 against cyclin D1 from Santa Cruz Biotechnologies. The Rb antibody G3-245 was from BD Pharmingen. Peptide antisera 128 against Brf, Ab4 against TFIIIC220, MTBP-6 against TBP and 1898 against TFIIIC90 have been described previously (7,23,25,27,28). Antibody 3208 against TFIIIC110 was raised by immunizing rabbits with synthetic peptide GEAGPVGNMTVVDSP (human TFIIIC110 residues 12-26) coupled to keyhole limpet haemocyanin.
###end p 20
###begin title 21
Immunoprecipitation
###end title 21
###begin p 22
###xml 65 67 64 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">26</xref>
Whole cell extracts (150 mug), prepared as described previously (26), were incubated in an orbital shaker for 3 h at 4degreesC with 30 mul of protein G beads carrying equivalent amounts of pre-bound IgG. Samples were pelleted and the beads washed five times with PBS. The bound material was analysed by western blotting.
###end p 22
###begin title 23
Primer extension
###end title 23
###begin p 24
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
Total RNA was extracted using TRI reagent, according to manufacturers' instructions. RNA was then analysed by primer extension using labelled primers specific for VA1 5'-CACGCGGGCGGTAACCGCATG-3' and green fluorescent protein (GFP) 5'-CGTCGCCGTCCAGCTCGACCAG-3'. Primer extension assays were performed as described previously (20).
###end p 24
###begin title 25
RT-PCR
###end title 25
###begin p 26
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
RT-PCR analysis of ARPP P0 mRNA, 5S rRNA and tRNA transcripts were performed as described previously (29,30).
###end p 26
###begin title 27
Northern blotting
###end title 27
###begin p 28
###xml 59 61 59 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 125 130 <span type="species:ncbi:10090">mouse</span>
Northern blotting was carried out as described previously (28). The ARPP P0 probe was a 1 kb EcoRI-HindIII fragment from the mouse cDNA (31). The tRNA probe was a 240 bp EcoRI-HindIII fragment from pLeu (32).
###end p 28
###begin title 29
Immunofluorescence microscopy
###end title 29
###begin p 30
###xml 177 181 <span type="species:ncbi:9925">goat</span>
###xml 412 416 <span type="species:ncbi:9925">goat</span>
###xml 422 427 <span type="species:ncbi:10090">mouse</span>
Cells on coverslips were fixed in 4% para-formaldehyde in PBS for 10 min, followed by permeabilization in 0.1% Triton X-100 in PBS for 4 min. Cells were washed, blocked in 0.1% goat serum and 0.2% fish skin gelatin in PBS, before incubation with primary antibody (HA from Santa Cruz) at 1:100 or 1:500 dilution. Cells were again washed and blocked followed by incubation with secondary antibody (Alexa Fluor 488 goat anti-mouse IgG, from Molecular Probes) at 1:400 dilution. Cells were washed with PBS and mounted on to glass slides and viewed using a Zeiss Axiovert fluorescence microscope.
###end p 30
###begin title 31
Chromatin immunoprecipitation (ChIP)
###end title 31
###begin p 32
###xml 43 45 43 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">33</xref>
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 266 268 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 269 271 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">33</xref>
ChIP assays were carried out as described (33). The antibodies used were MTBP-6 against TBP (27), 4286 against TFIIIC110 (25), F-7 against HA and SI-1 against TFIIB (both from Santa Cruz Biotechnologies). Primers and cycling parameters were as described previously (29,33). Serial dilutions of chromatin were used to confirm PCRs were within a linear range.
###end p 32
###begin title 33
RESULTS
###end title 33
###begin title 34
Transient transfection of a TFIIIC110 expression vector has minimal effect on pol III transcription in HeLa and HEK293 cells
###end title 34
###begin p 35
###xml 303 304 303 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 305 307 305 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 545 554 545 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2A</xref>
###xml 683 698 683 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2B and C</xref>
###xml 353 356 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
A mammalian expression vector was constructed that allows overexpression of an mRNA encoding HA-tagged TFIIIC110. This construct was transiently transfected into HEK293 cells along with the adenoviral VA1 gene, the pol III-transcribed gene used in the original studies by Hoeffler, Kovelman and Roeder (5,12). A vector encoding GFP transcribed from the CMV promoter was cotransfected as a control for transfection efficiency. Western blotting for the HA tag confirmed that the exogenous TFIIIC110 protein was expressed in the transfected cells (Figure 2A). However, little or no effect was seen in multiple experiments on the level of VA1 transcript, as assayed by primer extension (Figure 2B and C).
###end p 35
###begin p 36
###xml 287 289 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 605 620 605 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3A and B</xref>
###xml 734 743 722 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3C</xref>
The lack of response in HEK293 cells might be explained by the fact that this line expresses E1A, which was reported to elevate TFIIIC110 expression; the ratio of this polypeptide with respect to other TFIIIC subunits may already be high in these cells, such that TFIIIC2a predominates (12). Therefore, we repeated the experiment in HeLa cells, which were reported to have a significant fraction of TFIIIC2b, which lacks the TFIIIC110 subunit. In contrast to HEK293 cells, a modest, dose-dependent induction of VA1 RNA was observed when the HA-TFIIIC110 expression vector was transfected into HeLa cells (Figure 3A and B). After normalization to the cotransfected GFP internal control, the average response was approximately1.5-fold (Figure 3C).
###end p 36
###begin p 37
###xml 259 260 259 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 261 262 261 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 381 396 369 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3D and E</xref>
###xml 598 600 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
RT-PCR analysis was used to determine if levels of the endogenous pol III transcripts are influenced by transient transfection of the HA-TFIIIC110 vector. We examined expression of 5S rRNA and tRNA genes, both of which require TFIIIC for their transcription (1-3). No reproducible induction was observed for 5S rRNA, whereas tRNA showed a slight response of approximately1.5-fold (Figure 3D and E). Although, this assay measures the steady-state level of 5S rRNA, our tRNA primers are specific for short-lived primary transcripts, which are considered to reflect the rate of ongoing transcription (29). This approach therefore provided limited support for the model that class III gene expression can be stimulated by a specific increase in the ratio of TFIIIC110 to other TFIIIC subunits.
###end p 37
###begin title 38
Stable induction of TFIIIC110 in HeLa cells has little effect on expression of tRNA and 5S rRNA
###end title 38
###begin p 39
###xml 19 34 19 34 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3D and E</xref>
###xml 890 899 890 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4A</xref>
###xml 975 984 975 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4B</xref>
###xml 1120 1135 1120 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4B and C</xref>
The experiments in Figure 3D and E measured levels of endogenous transcripts in the total cell population. However, immunofluorescence analysis of GFP expression from the cotransfected control vector indicated that many of the HeLa cells remain untransfected under the conditions of our assays (data not shown). Since the presence of untransfected cells may partially mask a response, we produced HeLa cell clones that were stably transfected in the presence of a selectable marker, to ensure that the entire population receives the expression vector. The TFIIIC110 cDNA was subcloned into pTRE2hyg, which carries a doxycycline-responsive promoter. This was then used to produce multiple clones in which HA-tagged TFIIIC110 can be induced specifically by addition of doxycycline to the culture medium. Individual clones varied considerably in the levels of HA-TFIIIC110 that were produced (Figure 4A). We also observed clonal variation in the expression of tRNA and 5S rRNA (Figure 4B). However, RT-PCR analysis revealed no consistent change in the expression of pol III transcripts following induction of HA-TFIIIC110 (Figure 4B and C).
###end p 39
###begin p 40
###xml 13 21 13 21 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 207 208 207 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 295 304 295 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5A</xref>
###xml 400 402 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 403 405 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">34</xref>
###xml 406 408 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">35</xref>
###xml 465 474 465 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5B</xref>
###xml 591 600 591 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5C</xref>
###xml 659 668 659 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5D</xref>
###xml 760 775 760 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5E and F</xref>
The model in Figure 1 predicts that pol III transcription might be more sensitive to TFIIIC110 induction under low serum conditions. Therefore, we cultured HeLa cells in 0.5% serum, as in the previous work (9,12). This treatment was sufficient to cause a marked reduction in cell proliferation (Figure 5A). Trypan blue staining did not reveal any substantial apoptosis (data not shown). As expected (32,34,35), tRNA expression was markedly diminished in low serum (Figure 5B). This was accompanied by a slight decrease in expression of endogenous TFIIIC110, as revealed by western blotting (Figure 5C). HA-TFIIIC110 remained inducible under these conditions (Figure 5D), but we again found that its induction has little or no effect on tRNA or 5S rRNA levels (Figure 5E and F).
###end p 40
###begin p 41
###xml 484 493 484 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6A</xref>
###xml 964 973 964 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7A</xref>
###xml 1142 1151 1142 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7B</xref>
###xml 1473 1482 1473 1482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7C</xref>
###xml 1787 1794 1787 1794 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1967 1976 1967 1976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7C</xref>
Control experiments were conducted to verify that the exogenous HA-TFIIIC110 is incorporated into TFIIIC complexes. Sequence analysis using the PSORT II programme () revealed a strong nuclear localization signal (NLS) in TFIIIC220, but not in the other TFIIIC subunits. Unincorporated HA-TFIIIC110 may therefore be retained in the cytoplasm. Indeed, cytoplasmic fluorescence was detected with antibody against the HA tag following addition of doxycycline to the stable transfectants (Figure 6A). However, an intense immunofluorescence signal was also observed from the nuclei. This is consistent with the possibility that although some of the induced protein may remain unincorporated and hence in the cytoplasm, a significant proportion associates with TFIIIC220 to form a complex that enters the nucleus. Complex assembly is supported by the finding that HA-TFIIIC110 can be coimmunoprecipitated from doxycycline-treated cells using antiserum against TFIIIC220 (Figure 7A). Other TFIIIC subunits also associate with the HA-TFIIIC110, as shown by the fact that anti-HA antibody coimmunoprecipitates TFIIIC90 following doxycycline treatment (Figure 7B). This interaction is specific, since TFIIIC90 is not detected after control immunoprecipitations using antibodies against RB or cyclin D1. In addition, HA-TFIIIC110 is detected by ChIP at chromosomal tRNA and 5S rRNA genes, but not at the gene encoding TFIIIC220, which we used as a pol II-transcribed negative control (Figure 7C). In contrast, the pol II-specific transcription factor TFIIB is detected at the TFIIIC220 gene, but not at tRNA or 5S rRNA genes, as expected. These data confirm that the doxycycline-induced exogenous HA-TFIIIC110 is incorporated into TFIIIC complexes that are recruited to the appropriate target genes in vivo. However, ChIP with an antibody that recognizes total TFIIIC110 (i.e. both endogenous and HA-tagged forms), shows no increase in gene occupancy in response to doxycycline (Figure 7C, lanes 3 and 4). The data suggest that although stable transfection with an inducible construct is able to raise the total level of TFIIIC110 in HeLa cells, it has little impact on the amount of this subunit that is assembled onto promoters. This is consistent with the lack of a significant transcriptional response.
###end p 41
###begin title 42
Stable induction of Brf1 in HeLa cells can stimulate expression of tRNA and 5S rRNA
###end title 42
###begin p 43
###xml 881 890 881 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig8">Figure 8A</xref>
###xml 956 965 956 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6B</xref>
###xml 1098 1113 1098 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig8">Figure 8B and C</xref>
The data above show that specific induction of TFIIIC110 in HeLa cells has minimal effect on the expression of endogenous tRNA and 5S rRNA, even though the induced protein interacts with other TFIIIC subunits and is recruited to the appropriate template genes. Since this can be viewed as a negative result, it was necessary to confirm that the system we have used is amenable to transcriptional induction if a limiting factor is employed. We chose to try the Brf1 subunit of TFIIIB, as this has been shown to stimulate tRNA and 5S rRNA gene transcription when titrated into HeLa cell extracts. Therefore, we prepared stably transfected HeLa cell clones that carry doxycycline-inducible HA-tagged Brf1, using exactly the same approach as described above for HA-TFIIIC110. Blotting for the HA tag confirmed that HA-Brf1 can be induced in these cells by the addition of doxycycline (Figure 8A). A high proportion of this protein is localized to the nucleus (Figure 6B). Furthermore, RT-PCR analysis showed that tRNA and 5S rRNA levels are increased significantly in response to induction of HA-Brf1 (Figure 8B and C). This confirms that the doxycycline-regulated system used in these experiments can be exploited to activate pol III transcription. Therefore, we infer that a specific increase in the level of TFIIIC110 may not be an effective mechanism for pol III regulation in HeLa cells, as postulated.
###end p 43
###begin title 44
DISCUSSION
###end title 44
###begin p 45
###xml 187 188 187 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
In these experiments we have tested directly the model that TFIIIC110 is 'a central controlling subunit' for pol III transcription of TFIIIC-dependent promoters, as suggested previously (9). Our data do not support this idea. A weak induction by TFIIIC110 was observed for the VA1 and tRNA genes in transiently transfected cells, but this was only around 1.5-fold. Furthermore, this small effect was not reproducible in stably transfected cells. 5S rRNA gene expression did not respond to TFIIIC110 induction under either circumstance. In contrast, induction of Brf1 produces a strong increase in tRNA and 5S rRNA expression under the same conditions. We have confirmed that the induced TFIIIC110 can interact with other TFIIIC subunits, enter the nucleus and be recruited specifically to target genes. However, this has little effect on the overall amounts of TFIIIC110 being recruited to chromosomal genes. The data suggest that this subunit is not limiting in the contexts we have investigated.
###end p 45
###begin p 46
###xml 136 137 136 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 138 139 138 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 283 284 283 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 554 555 554 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
It was reported that several unidentified polypeptides co-purified with inactive TFIIIC2b and were not associated with active TFIIIC2a (5,9). In particular, a polypeptide of 77 kDa co-fractionated consistently with TFIIIC2b, although it was never detected by co-immunoprecipitation (9). As it was unclear whether this was a contaminant or had functional significance, the model of TFIIIC regulation by differential interaction with TFIIIC110 included the possibility that TFIIIC2b might contain an additional 77 kDa subunit as well as lacking TFIIIC110 (9). As far as we are aware, the identity of this putative subunit has not been reported. Clearly, the possibility of its involvement has not been addressed by our study.
###end p 46
###begin p 47
###xml 32 38 32 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 88 89 88 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 248 249 248 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 450 451 450 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 452 454 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 711 718 711 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Experiments carried out by Shen et al. lead them to question the existence of TFIIIC2b (7). These authors raised an antiserum against TFIIIC110 that, when used in an EMSA, was able to block all the DNA-binding activity of TFIIIC in a HeLa extract (7). This finding clearly conflicts with the report that a significant fraction of HeLa cell TFIIIC exists in a form (i.e. TFIIIC2b) that lacks TFIIIC110 but is undiminished in its DNA-binding capacity (5,12). We have been unable to address this issue because our antisera against TFIIIC110 are unable to block or supershift in an EMSA. Our study has specifically examined the hypothesis that selective induction of TFIIIC110 is a significant regulatory mechanism in vivo.
###end p 47
###begin p 48
###xml 252 254 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36">36</xref>
###xml 255 257 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b41">41</xref>
###xml 322 323 322 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b41">41</xref>
###xml 614 616 614 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b42">42</xref>
###xml 760 762 760 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b42">42</xref>
###xml 939 941 939 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b43">43</xref>
Another unresolved question with regard to mammalian TFIIIC concerns the identity of TFIIIC1, a TFIIIC-associated fraction that was found to be required for transcription of all types of pol III template using partially-purified reconstituted systems (36-41). Although candidate components of TFIIIC1 have been suggested (9,41), the functional significance of these polypeptides has not been demonstrated, as far as we are aware. Indeed, efficient pol III transcription of a U6 gene has been reconstituted more recently using a combination of recombinant and highly purified proteins without any TFIIIC1 fraction (42). It was suggested that TFIIIC1 might in fact correspond to Bdp1, an essential subunit of TFIIIB that dissociates readily during purification (42). This possibility is supported by the finding that Bdp1 co-fractionates with TFIIIC1 activity and can substitute for TFIIIC1 fractions in a reconstituted transcription assay (43).
###end p 48
###begin p 49
###xml 133 134 133 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 135 136 135 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 137 139 137 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 438 444 438 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 651 659 651 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 664 671 664 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 673 675 673 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 800 802 800 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b44">44</xref>
###xml 915 917 915 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">33</xref>
###xml 918 920 918 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b45">45</xref>
The model of TFIIIC110 induction was proposed as a mechanism to explain the activation of pol III transcription by E1A and by serum (5,9,12). We have not examined whether E1A can selectively stimulate TFIIIC110 expression, but our data suggest that this would have little impact on transcriptional output, at least in HeLa cells. Other documented mechanisms may instead account for pol III activation under these circumstances. Yoshinaga et al. (16) demonstrated that overall levels of TFIIIC had increased 4- to 8-fold 30 h after adenovirus infection of HeLa cells. In addition, E1A can overcome RB-mediated repression of pol III transcription, both in vitro and in vivo (20). Serum stimulation leads to a phosphorylation-mediated inactivation of RB and so can also derepress the pol III machinery (44). Furthermore, pol III transcription is directly activated by c-Myc and Erk, both of which are serum-inducible (33,45). Combinations of these mechanisms may be sufficient to explain pol III responsiveness to E1A and to serum.
###end p 49
###begin p 50
The authors thank Y. Shen and A. Berk for the Ab4 antibody, J. Flint for the MTBP-6 antibody and R. Roeder for the pRSET-TFIIIC110 vector. This work was funded by grant 068710 from the Wellcome Trust. Funding to pay the Open Access publication charges for this article was provided by grant 068710 from the Wellcome Trust.
###end p 50
###begin p 51
###xml 0 31 0 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement.</italic>
Conflict of interest statement. None declared.
###end p 51
###begin title 52
REFERENCES
###end title 52
###begin article-title 53
The RNA polymerase III transcription apparatus
###end article-title 53
###begin article-title 54
Recruitment of RNA polymerase III to its target promoters
###end article-title 54
###begin article-title 55
Purification and characterization of transcription factor IIIC2
###end article-title 55
###begin article-title 56
###xml 50 55 <span type="species:ncbi:9606">human</span>
Purification and characterization of two forms of human transcription factor IIIC
###end article-title 56
###begin article-title 57
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human transcription factor IIIC box B binding subunit
###end article-title 57
###begin article-title 58
###xml 101 111 <span type="species:ncbi:138953">poliovirus</span>
DNA binding domain and subunit interactions of transcription factor IIIC revealed by dissection with poliovirus 3C protease
###end article-title 58
###begin article-title 59
Cloning and characterization of an evolutionarily divergent DNA-binding subunit of mammalian TFIIIC
###end article-title 59
###begin article-title 60
Cloning and characterization of a TFIIIC2 subunit (TFIIICbeta) whose presence correlates with activation of RNA polymerase III-mediated transcription by adenovirus E1A expression and serum factors
###end article-title 60
###begin article-title 61
###xml 98 103 <span type="species:ncbi:9606">human</span>
Cloning and characterization of two evolutionarily conserved subunits (TFIIIC102 and TFIIIC63) of human TFIIIC and their involvement in functional interactions with TFIIIB and RNA polymerase III
###end article-title 61
###begin article-title 62
The TFIIIC90 subunit of TFIIIC interacts with multiple components of the RNA polymerase III machinery and contains a histone-specific acetyltransferase activity
###end article-title 62
###begin article-title 63
Activation of transcription factor IIIC by the adenovirus E1A protein
###end article-title 63
###begin article-title 64
Differential activation of RNA polymerase III-transcribed genes by the polyomavirus enhancer and the adenovirus E1A gene products
###end article-title 64
###begin article-title 65
Transcription of class III genes activated by viral immediate early proteins
###end article-title 65
###begin article-title 66
Enhancement of RNA polymerase III transcription by the E1A gene product of adenovirus
###end article-title 66
###begin article-title 67
Adenovirus stimulation of transcription by RNA polymerase III: evidence for an E1A-dependent increase in transcription factor IIIC concentration
###end article-title 67
###begin article-title 68
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trans</italic>
###xml 59 63 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Trans-activation of RNA polymerase II and III promoters by SV40 small t antigen
###end article-title 68
###begin article-title 69
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">trans</italic>
###xml 4 21 <span type="species:ncbi:10407">hepatitis B virus</span>
The hepatitis B virus X-gene product trans-activates both RNA polymerase II and III promoters
###end article-title 69
###begin article-title 70
###xml 50 55 <span type="species:ncbi:9606">human</span>
###xml 83 100 <span type="species:ncbi:28285">adenovirus type 5</span>
Activation of RNA polymerase III transcription of human Alu repetitive elements by adenovirus type 5: requirement for the E1b 58-kilodalton protein and the products of E4 open reading frames 3 and 6
###end article-title 70
###begin article-title 71
Repression of RNA polymerase III transcription by the retinoblastoma protein
###end article-title 71
###begin article-title 72
###xml 62 77 <span type="species:ncbi:10633">Simian virus 40</span>
Regulation of RNA polymerase III transcription in response to Simian virus 40 transformation
###end article-title 72
###begin article-title 73
###xml 71 86 <span type="species:ncbi:10633">simian virus 40</span>
Activation of RNA polymerase III transcription in cells transformed by simian virus 40
###end article-title 73
###begin article-title 74
Multiple mechanisms contribute to the activation of RNA polymerase III transcription in cells transformed by papovaviruses
###end article-title 74
###begin article-title 75
Ordering promoter binding of class III transcription factors TFIIIC1 and TFIIIC2
###end article-title 75
###begin article-title 76
Retinoblastoma protein disrupts interactions required for RNA polymerase III transcription
###end article-title 76
###begin article-title 77
Mitotic regulation of a TATA-binding-protein-containing complex
###end article-title 77
###begin article-title 78
Specific transcription from the adenovirus E2E promoter by RNA polymerase III requires a subpopulation of TFIID
###end article-title 78
###begin article-title 79
p53 is a general repressor of RNA polymerase III transcription
###end article-title 79
###begin article-title 80
RNA polymerase III transcription factor TFIIIC2 is overexpressed in ovarian tumours
###end article-title 80
###begin article-title 81
p53 represses RNA polymerase III transcription by targeting TBP and inhibiting promoter occupancy by TFIIIB
###end article-title 81
###begin article-title 82
pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes
###end article-title 82
###begin article-title 83
Regulation of RNA polymerase III transcription in response to F9 embryonal carcinoma stem cell differentiation
###end article-title 83
###begin article-title 84
Direct activation of RNA polymerase III transcription by c-Myc
###end article-title 84
###begin article-title 85
Changes in RNA in relation to growth of the fibroblast. I. Amounts of mRNA, rRNA, and tRNA in resting and growing cells
###end article-title 85
###begin article-title 86
Regulation of pre-transfer RNA synthesis during transition from resting to growing state
###end article-title 86
###begin article-title 87
Separation of TFIIIC into two functional components by sequence specific DNA affinity chromatography
###end article-title 87
###begin article-title 88
###xml 14 19 <span type="species:ncbi:9606">human</span>
Resolution of human transcription factor TFIIIC into two functional components
###end article-title 88
###begin article-title 89
Proximal sequence element-binding transcription factor (PTF) is a multisubunit complex required for transcription of both RNA polymerase II- and RNA polymerase III-dependent small nuclear RNA genes
###end article-title 89
###begin article-title 90
TFIIIC1 acts through a downstream region to stabilize TFIIIC2 binding to RNA polymerase III promoters
###end article-title 90
###begin article-title 91
###xml 32 33 32 33 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 39 40 39 40 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 67 68 67 68 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human transcription factors IIIC2, IIIC1 and a novel component IIIC0 fulfill different aspects of DNA binding to various pol III genes
###end article-title 91
###begin article-title 92
###xml 46 51 <span type="species:ncbi:9606">human</span>
DNA topoisomerase I and PC4 can interact with human TFIIIC to promote both accurate termination and transcription reinitiation by RNA polymerase III
###end article-title 92
###begin article-title 93
###xml 55 60 <span type="species:ncbi:9606">human</span>
A minimal RNA polymerase III transcription system from human cells reveals positive and negative roles for CK2
###end article-title 93
###begin article-title 94
###xml 70 82 70 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Homo sapiens</italic>
###xml 70 82 <span type="species:ncbi:9606">Homo sapiens</span>
###xml 121 126 <span type="species:ncbi:9606">human</span>
Transcription factor (TF)-like nuclear regulator, the 250-kDa form of Homo sapiens TFIIIB', is an essential component of human TFIIIC1 activity
###end article-title 94
###begin article-title 95
Regulation of RNA polymerase III transcription during cell cycle entry
###end article-title 95
###begin article-title 96
The mitogen-activated protein (MAP) kinase ERK induces tRNA synthesis by phosphorylating TFIIIB
###end article-title 96
###begin title 97
Figures and Tables
###end title 97
###begin p 98
Model proposing that an inactive form of TFIIIC, called TFIIIC2b, is converted to an active form, called TFIIIC2a, by the selective induction of TFIIIC110 in response to serum or E1A. Both forms bind to promoter DNA, but only TFIIIC2a is competent to support transcription.
###end p 98
###begin p 99
###xml 126 127 126 127 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 325 326 324 325 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 531 532 528 529 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
Transient transfection of a HA-TFIIIC110 expression vector has little or no effect on VA1 transcript levels in HEK293 cells. (A) Western blot of HEK293 cells transfected with pcDNA3HA-TFIIIC110 and/or pcDNA3HA to a total concentration of 2 mug. Upper panel shows a blot for HA-TFIIIC110, lower panel shows a blot for actin. (B) Primer extension analysis of VA1 and GFP RNA in HEK293 cells transfected with 0.25 mug of each of the VA1 and GFP plasmids and with pcDNA3HA-TFIIIC110 and/or pcDNA3HA to a total concentration of 2 mug. (C) Quantitation of the data from (B) and three identical experiments.
###end p 99
###begin p 100
###xml 159 160 159 160 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 357 358 356 357 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 602 603 599 600 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 635 644 632 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B</xref>
###xml 680 681 677 678 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 850 851 846 847 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
Transient transfection of a HA-TFIIIC110 expression vector has only a minor effect on VA1 reporter or endogenous pol III transcript expression in HeLa cells. (A) Western blots of HeLa cells transfected with pcDNA3HA-TFIIIC110 and/or pcDNA3HA to a total concentration of 2 mug. Upper panel shows a blot for HA-TFIIIC110, lower panel shows a blot for actin. (B) Primer extension analysis of VA1 and GFP RNA in HeLa cells transfected with 0.25 mug of each of the VA1 and GFP plasmids and with pcDNA3HA-TFIIIC110 and/or pcDNA3HA to a total concentration of 2 mug. Note that lane 3 is somewhat overloaded. (C) Quantitation of the data from Figure 3B and three additional experiments. (D) RT-PCR analysis of 5S rRNA, tRNA and ARPP P0 mRNA, as indicated, in HeLa cells transfected with pcDNA3HA-TFIIIC110 and/or pcDNA3HA to a total concentration of 2 mug. (E) Quantitation of the data from (D) and three additional experiments.
###end p 100
###begin p 101
###xml 137 138 137 138 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 376 377 376 377 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 579 580 579 580 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
Stable expression of HA-TFIIIC110 has little or no effect on endogenous pol III transcript levels in actively proliferating HeLa cells. (A) Western blot of HeLa cell clones stably transfected with pTRE2hygHA-TFIIIC110 and cultured in 10% serum in the presence or absence of doxycycline for 48 h. Upper panel shows a blot for HA-TFIIIC110, lower panel shows a blot for actin. (B) RT-PCR analysis of 5S rRNA, tRNA and ARPP P0 mRNA, as indicated, in HeLa cells stably transfected with pTRE2hygHA-TFIIIC110 and grown in 10% serum in the presence or absence of doxycycline for 48 h. (C) Quantitation of the data from three independent HeLa cell clones stably transfected with pTRE2hygHA-TFIIIC110 and grown in 10% serum in the presence or absence of doxycycline.
###end p 101
###begin p 102
###xml 136 137 136 137 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 232 233 232 233 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 413 416 412 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leu</sup>
###xml 520 521 519 520 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 643 644 642 643 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 883 884 882 883 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 1090 1091 1089 1090 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
Stable expression of HA-TFIIIC110 has little or no effect on endogenous pol III transcript levels in HeLa cells cultured in low serum. (A) Proliferation curve of HeLa cells cultured for 7 days in media containing 0.5 or 10% serum. (B) Northern blot analysis of total RNA (10 mug) extracted from HeLa cells cultured for 4 days in media containing 0.5 or 10% serum. The upper panel shows the blot probed with a tRNALeu gene and the lower panel shows the same blot, which has been stripped and re-probed for ARPP P0 mRNA. (C) Western blot of endogenous TFIIIC110 and actin in HeLa cells cultured for 4 days in media containing 0.5 or 10% serum. (D) Western blot of HeLa cells stably transfected with pTRE2hygHA-TFIIIC110 and cultured in 0.5 or 10% serum in the presence or absence of doxycycline for 48 h. Upper panel shows a blot for HA-TFIIIC110, lower panel shows a blot for actin. (E) RT-PCR analysis of 5S rRNA, tRNA and ARPP P0 mRNA, as indicated, in HeLa cells stably transfected with pTRE2hygHA-TFIIIC110 and cultured in 0.5% serum in the presence or absence of doxycycline for 48 h. (F) Quantitation of the data from three independent HeLa cell clones stably transfected with pTRE2hygHA-TFIIIC110 and cultured in 0.5% serum in the presence or absence of doxycycline.
###end p 102
###begin p 103
###xml 192 193 192 193 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 215 216 215 216 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
Immunofluorescence analysis of the subcellular distribution of HA-TFIIIC110 and HA-Brf1. Left panels show the localization of HA antigen in cells stably transfected with pTRE2hygHA-TFIIIC110 (A) or pTRE2hygHA-Brf1 (B) and cultured without doxycycline (upper panels) or induced with doxycycline for 48 h (lower panels). Right panels show DAPI staining of the same cells.
###end p 103
###begin p 104
###xml 83 84 83 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 430 431 430 431 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 771 772 771 772 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1178 1181 1178 1181 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leu</sup>
HA-TFIIIC110 associates with other TFIIIC subunits and pol III-transcribed genes. (A) Western blot using anti-HA antibody of material immunoprecipitated using preimmune serum (lanes 3 and 4) or antiserum against TFIIIC220 (lanes 5 and 6), as well as 10% inputs (lanes 1 and 2), from pTRE2hygHA-TFIIIC110 stably transfected HeLa cells cultured in the absence (odd-numbered lanes) or presence (even-numbered lanes) of doxycycline. (B) Proteins immunoprecipitated using monoclonal antibodies against RB (lanes 1 and 2), HA (lanes 3 and 4) and cyclin D1 (lanes 5 and 6) from pTRE2hygHA-TFIIIC110 stably transfected HeLa cells cultured in the absence (odd-numbered lanes) or presence (even-numbered lanes) of doxycycline were western blotted with antiserum against TFIIIC90. (C) ChIP assay using pTRE2hygHA-TFIIIC110 stably transfected cells cultured in the absence or presence of doxycycline, as indicated. Cross-linked chromatin was immunoprecipitated using antibodies against TBP, TFIIIC110, HA or TFIIB, or was mock-immunoprecipitated with beads unattached to antibody, as indicated. Immunoprecipitated material was PCR amplified using primers to the genes encoding 5S rRNA, tRNALeu and TFIIIC220, as indicated. Input panels show product intensities obtained using 10, 2 and 0.4% of input.
###end p 104
###begin p 105
###xml 107 108 107 108 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 326 327 326 327 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 524 525 524 525 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
Induction of HA-Brf1 can stimulate expression of tRNA and 5S rRNA genes in stably transfected HeLa cells. (A) Western blot of HeLa cell clones stably transfected with pTRE2hygHA-Brf1 and grown in the presence or absence of doxycycline for 48 h. The upper panel shows a blot for HA and the lower panel shows a blot for actin. (B) RT-PCR analysis of 5S rRNA, tRNA and ARPP P0 mRNA, as indicated, in HeLa cells stably transfected with pTRE2hygHA-Brf1 and grown in 10% serum in the presence or absence of doxycycline for 48 h. (C) Quantitation of the data shown in (B).
###end p 105

